The bone void fillers market size has grown strongly in recent years. It will grow from $3.78 billion in 2025 to $4.02 billion in 2026 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to increasing incidence of bone fractures and trauma, rising orthopedic surgical volumes, growing use of demineralized bone matrix, expansion of spinal fusion procedures, availability of advanced biomaterials.
The bone void fillers market size is expected to see strong growth in the next few years. It will grow to $5.18 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing aging population, rising demand for minimally invasive bone repair solutions, expansion of sports injury treatments, growing adoption of bioactive graft materials, increasing focus on regenerative medicine. Major trends in the forecast period include increasing adoption of synthetic bone graft substitutes, rising use of injectable bone void fillers, growing preference for osteoconductive biomaterials, expansion of minimally invasive orthopedic procedures, enhanced focus on faster bone regeneration.
The growing burden of bone diseases is expected to drive growth in the bone void filler market in the coming years. Bone diseases affect the structure and function of bones, often causing weakness, deformity, pain, and impaired growth or repair. Bone void fillers aid in treating these conditions by promoting bone growth and repair in damaged areas, accelerating healing, reducing pain, and improving the overall success of bone-related treatments. For example, in August 2023, the Institute for Health Metrics and Evaluation (IHME), a US-based research organization, projected that nearly 1 billion individuals will suffer from osteoarthritis by 2050, with knee osteoarthritis expected to rise by 75% and hand osteoarthritis by 50%. Consequently, the increasing prevalence of bone diseases is supporting growth in the bone void filler market.
Major companies operating in the bone void fillers market are focusing on innovations in materials and design, particularly carbohydrate polymer bone graft substitutes. These synthetic materials mimic the structure of natural bone, enhancing bone healing and regeneration in areas of bone loss. For instance, in May 2023, Royal Biologics, a US-based orthobiologics company, launched Bio-Reign 3D, a bone graft substitute made from a hyper-crosslinked natural carbohydrate polymer. It provides an optimal environment for cell growth and vascularization, aids bone regeneration, and transitions from radiolucent to radiopaque as healing progresses, allowing clinicians to monitor recovery. The material also offers superior compression and tensile strength, as well as ease of use for shaping and applying the graft.
In April 2023, Henry Schein Inc., a US-based healthcare company, acquired a majority stake in Biotech Dental SAS for an undisclosed amount. This acquisition aims to strengthen digital integration between Biotech Dental’s software and Henry Schein’s product portfolio, streamlining workflows, improving patient outcomes, and supporting global expansion in implant and orthodontic solutions. Biotech Dental is a France-based provider of bone void fillers.
Major companies operating in the bone void fillers market are Johnson & Johnson, Medtronic plc, Heraeus Group, Stryker Corporation, Huntsman Corporation, Zimmer Biomet Holdings Inc., Smith and Nephew plc, Arthrex Inc., Globus Medical Inc., NuVasive Inc., Orthofix Medical Inc., Biocomposites Ltd., Aziyo Biologics Inc., Bone Support AB, Collagen Matrix Inc., Royal Biologics Inc., FlexForm Technologies, Orthorebirth Co. Ltd, Vivex Biologics, Mitsubishi Tanabe Pharma Corporation, OsteoBiologics Inc., Bacterin International Inc.
North America was the largest region in the bone void fillers market in 2025. The regions covered in the bone void fillers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bone void fillers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the bone void fillers market by increasing costs of imported biomaterials, calcium phosphate compounds, collagen matrices, and specialized manufacturing equipment used in graft substitute production. Hospitals and specialty clinics in North America and Europe are most affected due to dependence on imported raw materials and processing technologies, while Asia-Pacific faces pricing pressure on export-oriented manufacturing. These tariffs are raising procedure costs and influencing procurement decisions. However, they are also encouraging localized biomaterial sourcing, regional manufacturing expansion, and innovation in cost-effective synthetic bone filler solutions.
The bone void fillers market research report is one of a series of new reports that provides bone void fillers market statistics, including bone void fillers industry global market size, regional shares, competitors with a bone void fillers market share, detailed bone void fillers market segments, market trends and opportunities, and any further data you may need to thrive in the bone void fillers industry. This bone void fillers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Bone void fillers are materials utilized to fill defects or discontinuities in bone tissue, often arising from pathologic processes such as trauma, degenerative conditions, or neoplastic conditions. These fillers can be either synthetic or natural, serving as an osteoconductive matrix to facilitate the healing of bone.
The main types of bone void fillers include demineralized bone matrix, calcium phosphate bone graft substitutes, collagen matrix, and others. Calcium-phosphate bone graft substitutes typically consist of tricalcium phosphate or hydroxyapatite, which is the primary mineral found in bone. These fillers are available in various forms such as gel and putty, granules, and others. They find applications in various medical procedures such as bone fractures and spine fusion, and are used by different end-users, including hospitals and specialty clinics.
The bone void filler market consists of sales of demineralized bone matrix, bioactive glass, bone morphogenetic proteins, and human bone (autografts and allografts). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The bone void fillers market size is expected to see strong growth in the next few years. It will grow to $5.18 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing aging population, rising demand for minimally invasive bone repair solutions, expansion of sports injury treatments, growing adoption of bioactive graft materials, increasing focus on regenerative medicine. Major trends in the forecast period include increasing adoption of synthetic bone graft substitutes, rising use of injectable bone void fillers, growing preference for osteoconductive biomaterials, expansion of minimally invasive orthopedic procedures, enhanced focus on faster bone regeneration.
The growing burden of bone diseases is expected to drive growth in the bone void filler market in the coming years. Bone diseases affect the structure and function of bones, often causing weakness, deformity, pain, and impaired growth or repair. Bone void fillers aid in treating these conditions by promoting bone growth and repair in damaged areas, accelerating healing, reducing pain, and improving the overall success of bone-related treatments. For example, in August 2023, the Institute for Health Metrics and Evaluation (IHME), a US-based research organization, projected that nearly 1 billion individuals will suffer from osteoarthritis by 2050, with knee osteoarthritis expected to rise by 75% and hand osteoarthritis by 50%. Consequently, the increasing prevalence of bone diseases is supporting growth in the bone void filler market.
Major companies operating in the bone void fillers market are focusing on innovations in materials and design, particularly carbohydrate polymer bone graft substitutes. These synthetic materials mimic the structure of natural bone, enhancing bone healing and regeneration in areas of bone loss. For instance, in May 2023, Royal Biologics, a US-based orthobiologics company, launched Bio-Reign 3D, a bone graft substitute made from a hyper-crosslinked natural carbohydrate polymer. It provides an optimal environment for cell growth and vascularization, aids bone regeneration, and transitions from radiolucent to radiopaque as healing progresses, allowing clinicians to monitor recovery. The material also offers superior compression and tensile strength, as well as ease of use for shaping and applying the graft.
In April 2023, Henry Schein Inc., a US-based healthcare company, acquired a majority stake in Biotech Dental SAS for an undisclosed amount. This acquisition aims to strengthen digital integration between Biotech Dental’s software and Henry Schein’s product portfolio, streamlining workflows, improving patient outcomes, and supporting global expansion in implant and orthodontic solutions. Biotech Dental is a France-based provider of bone void fillers.
Major companies operating in the bone void fillers market are Johnson & Johnson, Medtronic plc, Heraeus Group, Stryker Corporation, Huntsman Corporation, Zimmer Biomet Holdings Inc., Smith and Nephew plc, Arthrex Inc., Globus Medical Inc., NuVasive Inc., Orthofix Medical Inc., Biocomposites Ltd., Aziyo Biologics Inc., Bone Support AB, Collagen Matrix Inc., Royal Biologics Inc., FlexForm Technologies, Orthorebirth Co. Ltd, Vivex Biologics, Mitsubishi Tanabe Pharma Corporation, OsteoBiologics Inc., Bacterin International Inc.
North America was the largest region in the bone void fillers market in 2025. The regions covered in the bone void fillers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bone void fillers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the bone void fillers market by increasing costs of imported biomaterials, calcium phosphate compounds, collagen matrices, and specialized manufacturing equipment used in graft substitute production. Hospitals and specialty clinics in North America and Europe are most affected due to dependence on imported raw materials and processing technologies, while Asia-Pacific faces pricing pressure on export-oriented manufacturing. These tariffs are raising procedure costs and influencing procurement decisions. However, they are also encouraging localized biomaterial sourcing, regional manufacturing expansion, and innovation in cost-effective synthetic bone filler solutions.
The bone void fillers market research report is one of a series of new reports that provides bone void fillers market statistics, including bone void fillers industry global market size, regional shares, competitors with a bone void fillers market share, detailed bone void fillers market segments, market trends and opportunities, and any further data you may need to thrive in the bone void fillers industry. This bone void fillers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Bone void fillers are materials utilized to fill defects or discontinuities in bone tissue, often arising from pathologic processes such as trauma, degenerative conditions, or neoplastic conditions. These fillers can be either synthetic or natural, serving as an osteoconductive matrix to facilitate the healing of bone.
The main types of bone void fillers include demineralized bone matrix, calcium phosphate bone graft substitutes, collagen matrix, and others. Calcium-phosphate bone graft substitutes typically consist of tricalcium phosphate or hydroxyapatite, which is the primary mineral found in bone. These fillers are available in various forms such as gel and putty, granules, and others. They find applications in various medical procedures such as bone fractures and spine fusion, and are used by different end-users, including hospitals and specialty clinics.
The bone void filler market consists of sales of demineralized bone matrix, bioactive glass, bone morphogenetic proteins, and human bone (autografts and allografts). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Bone Void Fillers Market Characteristics
3. Bone Void Fillers Market Supply Chain Analysis
4. Global Bone Void Fillers Market Trends and Strategies
5. Bone Void Fillers Market Analysis of End Use Industries
7. Global Bone Void Fillers Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Bone Void Fillers Total Addressable Market (TAM) Analysis for the Market
9. Bone Void Fillers Market Segmentation
10. Bone Void Fillers Market Regional and Country Analysis
11. Asia-Pacific Bone Void Fillers Market
12. China Bone Void Fillers Market
13. India Bone Void Fillers Market
14. Japan Bone Void Fillers Market
15. Australia Bone Void Fillers Market
16. Indonesia Bone Void Fillers Market
17. South Korea Bone Void Fillers Market
18. Taiwan Bone Void Fillers Market
19. South East Asia Bone Void Fillers Market
20. Western Europe Bone Void Fillers Market
21. UK Bone Void Fillers Market
22. Germany Bone Void Fillers Market
23. France Bone Void Fillers Market
24. Italy Bone Void Fillers Market
25. Spain Bone Void Fillers Market
26. Eastern Europe Bone Void Fillers Market
27. Russia Bone Void Fillers Market
28. North America Bone Void Fillers Market
29. USA Bone Void Fillers Market
30. Canada Bone Void Fillers Market
31. South America Bone Void Fillers Market
32. Brazil Bone Void Fillers Market
33. Middle East Bone Void Fillers Market
34. Africa Bone Void Fillers Market
36. Bone Void Fillers Market Competitive Landscape and Company Profiles
37. Bone Void Fillers Market Other Major and Innovative Companies
40. Bone Void Fillers Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Bone Void Fillers Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses bone void fillers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for bone void fillers? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bone void fillers market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Demineralized Bone Matrix; Calcium phosphate Bone Graft Substitute; Collagen Matrix; Other Types2) By Form: Gel And Putty; Granules; Other Forms
3) By Application: Bone Fracture; Spine Fusion; Other Applications
4) By End-User: Hospital; Specialty Clinics
Subsegments:
1) By Demineralized Bone Matrix: Freeze-Dried Demineralized Bone Matrix (FDBM); Demineralized Bone Matrix Putty2) By Calcium Phosphate Bone Graft Substitute: Hydroxyapatite; Tricalcium Phosphate
3) By Collagen Matrix: Collagen-Based Gel; Collagen-Based Sponge
4) By Other Types: Synthetic Bone Graft Substitutes; Bone Morphogenetic Proteins (BMPs)
Companies Mentioned: Johnson & Johnson; Medtronic plc; Heraeus Group; Stryker Corporation; Huntsman Corporation; Zimmer Biomet Holdings Inc.; Smith and Nephew plc; Arthrex Inc.; Globus Medical Inc.; NuVasive Inc.; Orthofix Medical Inc.; Biocomposites Ltd.; Aziyo Biologics Inc.; Bone Support AB; Collagen Matrix Inc.; Royal Biologics Inc.; FlexForm Technologies; Orthorebirth Co. Ltd; Vivex Biologics; Mitsubishi Tanabe Pharma Corporation; OsteoBiologics Inc.; Bacterin International Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Bone Void Fillers market report include:- Johnson & Johnson
- Medtronic plc
- Heraeus Group
- Stryker Corporation
- Huntsman Corporation
- Zimmer Biomet Holdings Inc.
- Smith and Nephew plc
- Arthrex Inc.
- Globus Medical Inc.
- NuVasive Inc.
- Orthofix Medical Inc.
- Biocomposites Ltd.
- Aziyo Biologics Inc.
- Bone Support AB
- Collagen Matrix Inc.
- Royal Biologics Inc.
- FlexForm Technologies
- Orthorebirth Co. Ltd
- Vivex Biologics
- Mitsubishi Tanabe Pharma Corporation
- OsteoBiologics Inc.
- Bacterin International Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.02 Billion |
| Forecasted Market Value ( USD | $ 5.18 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
